EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study

Dominique Bertrand, Nathalie Chavarot, Jérôme Olagne, Clarisse Greze, Philippe Gatault, Clément Danthu, Charlotte Colosio, Maïté Jaureguy, Agnès Duveau, Nicolas Bouvier, Yannick Le Meur, Léonard Golbin und 7 weitere

Transplant International · 2024

DOI: 10.3389/ti.2024.13544 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transplant International, 2024. Verfasst von Dominique Bertrand und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Kidney Transplantation and Hemodialysis, Rouen University Hospital, Rouen, France. Hauptthemen laut MEDLINE: Graft Rejection, Kidney Transplantation, Abatacept, Immunosuppressive Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

After kidney transplantation, conversion to belatacept is a promising alternative in patients with poor graft function or intolerance to calcineurin inhibitors. The risk of acute rejection has not been well described under these conditions. Here we present a retrospective multicenter study investigating the occurrence of acute rejection after conversion in 901 patients (2011–2021). The incidence of cellular and humoral rejection was 5.2% and 0.9%, respectively. T-cell mediated rejection (TCMR) occurred after a median of 2.6 months after conversion. Out of 47 patients with TCMR, death-censored graft survival was 70.1%, 55.1% and 50.8% at 1 year, 3 years and 5 years post-rejection, respectively. Eight patients died after rejection, mainly from infectious diseases. We compared these 47 patients with a cohort of kidney transplant recipients who were converted to belatacept between 2011 and 2017 and did not develop rejection (n = 238). In multivariate analysis, shorter time between KT and conversion, and the absence of anti-thymocyte globulin induction after KT were associated with the occurrence of TCMR after belatacept conversion. The occurrence of rejection after conversion to belatacept appeared to be less frequent than with de novo use. Nevertheless, the risk of graft loss could be significant in patients with already low renal function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionKidney TransplantationAbataceptImmunosuppressive AgentsGraft SurvivalT-LymphocytesHumansRetrospective StudiesMaleFemaleMiddle AgedAdultAgedBiopsy

Stichwörter der Autor:innen

CNI toxicitybelataceptkidneyrejectiontransplantation

Substanzen

AbataceptImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Nephrology, Kidney Transplantation and Hemodialysis, Rouen University Hospital, Rouen, France.
  • Department of Nephrology and Kidney Transplantation, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Department of Nephrology, Kidney Transplantation and Hemodialysis, Strasbourg University Hospital, Strasbourg, France.
  • Department of Nephrology, Kidney Transplantation and Hemodialysis, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
  • Department of Nephrology, Kidney Transplantation and Hemodialysis, Tours University Hospital, Tours, France.
  • Department of Nephrology, Kidney Transplantation and Hemodialysis, Limoges University Hospital, Limoges, France.

Zitieren

APA

Bertrand, D., Chavarot, N., Olagne, J., Greze, C., Gatault, P., Danthu, C., Colosio, C., Jaureguy, M., Duveau, A., Bouvier, N., Le Meur, Y., Golbin, L., Thervet, E., Thierry, A., François, A., Laurent, C., Lemoine, M., Anglicheau, D., & Guerrot, D. (2024). Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study. Transplant International. https://doi.org/10.3389/ti.2024.13544

Vancouver

Bertrand D, Chavarot N, Olagne J, Greze C, Gatault P, Danthu C, et al. Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study. Transplant International. 2024. doi:10.3389/ti.2024.13544

BibTeX
@article{Bertrand2024,
  author = {Bertrand, Dominique and Chavarot, Nathalie and Olagne, Jérôme and Greze, Clarisse and Gatault, Philippe and Danthu, Clément and Colosio, Charlotte and Jaureguy, Maïté and Duveau, Agnès and Bouvier, Nicolas and Le Meur, Yannick and Golbin, Léonard and Thervet, Eric and Thierry, Antoine and François, Arnaud and Laurent, Charlotte and Lemoine, Mathilde and Anglicheau, Dany and Guerrot, Dominique},
  title = {Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study},
  journal = {Transplant International},
  year = {2024},
  doi = {10.3389/ti.2024.13544}
}
Kostenlos starten →